-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
POINT Biopharma Global Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2020 to 2022.
- POINT Biopharma Global Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was -$153M, a 16165% decline year-over-year.
- POINT Biopharma Global Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$266M, a 2925% decline from 2021.
- POINT Biopharma Global Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$8.8M, a 10.2% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)